The Opportunity

A small but determined group of public health and vaccine experts — including vaccinologist Burt Dorman — have persisted over countless years in their efforts to advocate for the killed-virus approach. To date, that advocacy has largely occurred using traditional methods, directed towards traditional entities.

Recently, however, we have assembled an effort to pursue an entirely new opportunity — namely the support of individual philanthropists with enough resources to fund the project, enough backbone to stand up to potential naysayers, and enough common sense to understand that such a straightforward and well-understood solution deserves its day in the laboratory.

Within a handful of years, with a relatively small amount of funding, we can definitively assess whether a killed-virus vaccine can stop the AIDS pandemic. While no experienced vaccinologist would guarantee that any approach will definitively work, experts in the killed-virus method think that it very well might. Some are optimistic — even confident — that it will.

Fortunately, there is no need to speculate. We can do the experiments and find out.

This situation calls for a visionary philanthropic hero — one whose investment which may literally and dramatically change the course of history. We know that person is out there. Our task is to get this remarkable opportunity onto that person’s radar screen.